Also Read: Amneal’s Combination Drug Shows Improved Sleep Quality In Parkinson’s Disease Patients The company’s net income was $12 million in the first quarter of 2025. In the first quarter ...

BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported first-quarter net income of $12.2 million, after reporting a loss in the same period a ...

Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Amneal beat analysts’ revenue ...

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.5% year on year to $695.4 million. On the other hand, ...

Amneal expects full-year earnings in the range of 65 cents to 70 cents per share, with revenue in the range of $3 billion to $3.1 billion. Amneal shares have fallen slightly more than 2% since the ...